Chewable tablet containing astaxanthin nanoparticles and preparation method thereof
A technology of nanoparticles and astaxanthin, which is applied in medical preparations containing active ingredients, pharmaceutical formulas, and medical preparations with non-active ingredients, etc., can solve the problems of poor water solubility and poor bioavailability, and achieve low processing costs , Stable state, solve the effect of extremely low solubility
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0033] The chewable tablet containing astaxanthin nanoparticles in this embodiment includes the following raw materials in weight fraction: astaxanthin: 0.4 part, octenyl succinic acid keratin ester: 0.2 part, sucrose fatty acid ester: 0.008 part , Hypromellose: 50 parts, Maltodextrin: 45.992 parts, White sugar: 2 parts, Microcrystalline cellulose: 1 part, Ethyl maltol: 0.1 parts, Magnesium stearate: 0.2 parts, Aspartame : 0.1 serving.
[0034] Step 1, add 30 parts of pure water in the batching tank, start stirring, weigh 0.4 parts of astaxanthin and put it into the batching tank, continue to stir and open the high-speed colloid mill to superfinely pulverize the astaxanthin in the water, and control the period. The feed temperature was 25°C.
[0035] In step II, the pulverized material in step I was filtered through a 200-mesh filter screen, and the filtrate was homogenized at 130 MPa through a homogenizer. After at least 8 times of homogenization, the homogenization was stop...
Embodiment 2
[0039] The chewable tablet containing astaxanthin nanoparticles in this embodiment includes the following raw materials in weight fraction: astaxanthin: 0.4 part, octenyl succinic acid keratin ester: 0.3 part, sucrose fatty acid ester: 0.012 part , Hypromellose: 50 parts, Maltodextrin: 45.888 parts, White sugar: 2 parts, Microcrystalline cellulose: 1 part, Ethyl maltol: 0.1 part, Magnesium stearate: 0.2 part, Aspartame : 0.1 serving.
[0040] Step 1, add 20 parts of pure water in the batching tank, start stirring, weigh 0.4 part of astaxanthin and put it into the batching tank, continue to stir and open the high-speed colloid mill to superfinely pulverize the astaxanthin in the water, and control the period. The feed temperature was 25°C.
[0041] In step II, the pulverized material in step I is filtered through a 200-mesh filter screen, and the filtrate is homogenized by a homogenizer at 130 MPa. After at least 8 times of homogenization, the homogenization is stopped. Alken...
Embodiment 3
[0045] The chewable tablet containing astaxanthin nanoparticles in this embodiment includes the following raw materials in weight fraction: astaxanthin: 0.4 part, octenyl succinic acid keratin ester: 0.4 part, sucrose fatty acid ester: 0.016 part , Hypromellose: 50 parts, Maltodextrin: 45.784 parts, White sugar: 2 parts, Microcrystalline cellulose: 1 part, Ethyl maltol: 0.1 part, Magnesium stearate: 0.2 part, Aspartame : 0.1 serving.
[0046] Step 1, add 10 parts of pure water in the batching tank, start stirring, weigh 0.4 part of astaxanthin and put it into the batching tank, continue to stir and open the high-speed colloid mill to superfinely pulverize the astaxanthin in the water, and control the period. The material temperature is 25℃;
[0047] In step II, the pulverized material in step I was filtered through a 200-mesh filter screen, and the filtrate was homogenized at least 8 times at 130 MPa by a homogenizer, and then the homogenization was stopped, and then 0.016 pa...
PUM
| Property | Measurement | Unit |
|---|---|---|
| particle diameter | aaaaa | aaaaa |
| particle diameter | aaaaa | aaaaa |
| particle diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More